Evidence map›Paper›PMID 26768962›Full record

ArticleCurrent molecular pharmacology2017

Editorial (Thematic Issue: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part I)).

Saeid Ghavami, Nicholas J Kenyon, Behzad Yeganeh, Amir A Zeki

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Current molecular pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saeid GhavamiDepartment of Human Anatomy and Cell Sciences, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, 130-745 Bannatyne Ave., Winnipeg, MB R3E 0J9. Canada.
Nicholas J KenyonDivision of Pulmonary, Critical Care, Sleep Medicine Department of Internal Medicine Center for Comparative Respiratory Biology and Medicine University of California, Davis School of Medicine Davis, CA 95616. United States.
Behzad YeganehHospital for Sick Children & University of Toronto. Canada.
Amir A ZekiDivision of Pulmonary, Critical Care and Sleep Medicine Department of Internal Medicine Center for Comparative Respiratory Biology and Medicine University of California, Davis School of Medicine Davis, CA 95616. United States.

Funding

The Modulation of Eotaxin Expression by Statins: Implications for Asthma TherapyK08HL114882 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ZEKI, AMIR A. · 2014 to 2016
$435k
NHLBI NIH HHS K08 HL114882
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DiseaseCholesterolHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic AcidCholesterolHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic Acid

Identifiers

PMID26768962
PMCPMC6111027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.